Streetbeat News

Products Services

NVAX

Novavax has received Emergency Use Authorization from the Taiwan Food and Drug Administration for its updated COVID-19 vaccine. This approval could potentially boost the company's vaccine distribution and sales in Taiwan.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:04 pm

TSLA

The weekend's top stories included a public opinion poll showing dissatisfaction with both Joe Biden and Donald Trump, Elon Musk's reaction to the sentencing of ex-FBI official Charles McGonigal, debunked claims about Trump and a lemonade incident, a rally in Tesla Inc. (NASDAQ:TSLA) stock that rendered Senator Tommy Tuberville's put options worthless, and a prediction of a potential breakout for the cryptocurrency Shiba Inu.

Portfolio Pulse from Benzinga Neuro

December 18, 2023 | 1:03 pm

CRL

VRTX

Charles River Laboratories International (CRL) has reached a significant milestone in its strategic collaboration with Vertex Pharmaceuticals (VRTX) by obtaining approval for its Memphis facility to manufacture CASGEVY™, a gene-edited therapy for severe sickle cell disease.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:03 pm

ASTI

Ascent Solar Technologies has completed the first delivery of its new, high-efficiency solar material for further testing, marking a potential advancement in its product offerings.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:59 pm

AMZN

BABA

PDD

Alibaba Group Holding Ltd (NYSE:BABA) is expanding its global footprint to compete with platforms like Shein and PDD Holdings Inc's (NASDAQ:PDD) Temu. Alibaba.com launched a digital trade service base in Shanghai, introduced an AI tool for automating listings and customer service, and started a dedicated cargo flight between Shenzhen and Mexico City. Alibaba invested $634 million in Lazada, part of a $7.4 billion total investment since its acquisition. Alibaba's international revenue grew by 53% in Q3, surpassing domestic growth. Amazon.com Inc (NASDAQ:AMZN) and ByteDance's TikTok are also expanding in the region, with Amazon building an innovation center in Shenzhen and TikTok investing in Indonesia's GoTo Gojek Tokopedia. BABA shares were down 0.60% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

December 18, 2023 | 12:58 pm

FERG

CEO Warrior, a company offering business coaching and training for service businesses, has announced a collaboration with Ferguson, a major distributor of plumbing and HVAC supplies. This partnership aims to provide CEO Warrior members with preferred access to Ferguson's extensive range of products and services.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:55 pm

NVT

nVent Electric has partnered with Hyperview to enhance control and monitoring capabilities for data center customers' power distribution units. This collaboration aims to provide customers with better management tools for their data center operations.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:52 pm

VSTM

Verastem Oncology has announced GFH375/VS-7375 as the lead program from its collaboration with Genfleet Therapeutics. This program focuses on a potential oral inhibitor targeting KRAS G12D, a mutation involved in various cancers. The company plans to submit an Investigational New Drug (IND) application in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:50 pm

VRAX

Virax Biolabs Group Limited (VRAX) CEO James Foster issued a shareholder letter detailing the company's progress in immunology research, particularly in post viral syndromes and chronic inflammation. The company has developed a SARS-Cov-2 version of its ViraxImmune T-Cell Kit and is collaborating with a UK research institute. Virax is also enhancing its IVD platform with FluoroSpot technology for better immune response analysis. Financially, Virax is in a strong position with $5.6 million in cash and no debt after a warrant exercise in October 2023. The stock is currently trading at 57% of cash value. The company anticipates significant advancements in its FluoroSpot assays and expansion of distribution channels in the next 12 months.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 12:44 pm

AADI

DRRX

KTRA

The article highlights three health care stocks that are considered oversold based on their Relative Strength Index (RSI) values, suggesting a potential buying opportunity for undervalued companies. Kintara Therapeutics, Inc. (KTRA) has an RSI of 21.46 and experienced a 46% stock price drop over the past month. Aadi Bioscience, Inc. (AADI) reported interim trial results and saw a 54% decline in stock price over five days, with an RSI of 23.73. DURECT Corporation (DRRX) posted disappointing sales and a 9% stock price decrease over the past month, with an RSI of 27.92.

Portfolio Pulse from Avi Kapoor

December 18, 2023 | 12:39 pm